Elsevier And Elsevier Properties Sa

Provides Unprecedented Access to Detailed Drug Pharmacokinetics Data and Over 1,000,000 Extracted Exposure Observations From the FDA and EMEA Documents on More Than 2,100 Drugs

Older News

NEW YORK, September 14, 2010 - Elsevier today announces that it has significantly increased its service offering to pharmaceutical R&D professionals with the launch of a new Pharmacokinetics Module of PharmaPendium(TM), the online resource for authoritative drug development data.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy